CUB and Sushi multiple domains protein 1 (CSMD1) maps to 8p23, a region deleted in many cancers, and thought to be a tumour suppressor gene. Loss of CSMD1 expression is associated with reduced survival in breast cancer patients. CSMD1's function is unknown; however, CSMD1's structure suggests it is involved in signal transduction. Here, we have investigated the function of CSMD1. CSMD1 expression was silenced in MCF10A, MDA-MB-435 and LNCaP cell lines by shRNA and functional assays were performed.
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Loss of CSMD1 expression disrupted cell morphology and caused 30% (p < 0.001), 32% (p = 0.03) and 56% (p < 0.001) increase in cell proliferation of MDA-MB-435, LNCaP and MCF10A, respectively, compared to controls. Also MDA-MB-435 and MCF10A shCSMD1 cells showed reduced adhesion to matrigel (32%, p = 0.0005 and 44%, p = 0.0006, respectively), and to fibronectin (39%, p = 0.004 and 32%, p < 0.001, respectively). Moreover, loss Results: Compared to normal tissue, TIMM17A mRNA expression was higher in BC (p = 0.006), TNM-1 (p = 0.05), TNM-2 (p = 0.034), NPI-2 (p = 0.041), patients with progressive disease (p = 0.017) and those who died from BC (p = 0.026). Expression increased with tumour grade; grade 1 versus 2 (p = 0.007), grade 1 versus 3 (p = 0.065, NS) and grade 1 versus 2 and 3 (p = 0.0048).
Higher transcript levels were associated with ER-a positivity (p = 0.073, NS) and ER-b negativity (p = 0.015). Nodal positivity was significantly associated with higher transcript levels (p = 0.046). Compared to disease free patients, TIMM17A expression was significantly higher in those with progressive disease and patients who died of BC (p = 0.037). Higher transcript levels were significantly associated with poorer overall survival after a median follow-up of 10 years (p = 0.010). TIMM17A expression emerged as a strong independent predictor of overall survival in multivariate analysis (p = 0.033). 
Conclusion

